BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25826538)

  • 1. Should kidney donors be genotyped for APOL1 risk alleles?
    Freedman BI; Julian BA
    Kidney Int; 2015 Apr; 87(4):671-3. PubMed ID: 25826538
    [No Abstract]   [Full Text] [Related]  

  • 2. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
    Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Bowden DW; Hicks PJ; Palmer ND; Palanisamy A; Reeves-Daniel AM; Brown WM; Divers J
    Transplantation; 2016 Jan; 100(1):194-202. PubMed ID: 26566060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
    Riella LV; Sheridan AM
    Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African American living-kidney donors should be screened for APOL1 risk alleles.
    Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
    Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.
    Jotwani V; Shlipak MG; Scherzer R; Parekh RS; Kao WH; Bennett M; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Parikh CR; Estrella MM
    Am J Kidney Dis; 2015 Jun; 65(6):889-98. PubMed ID: 25921719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.
    Ito K; Bick AG; Flannick J; Friedman DJ; Genovese G; Parfenov MG; Depalma SR; Gupta N; Gabriel SB; Taylor HA; Fox ER; Newton-Cheh C; Kathiresan S; Hirschhorn JN; Altshuler DM; Pollak MR; Wilson JG; Seidman JG; Seidman C
    Circ Res; 2014 Feb; 114(5):845-50. PubMed ID: 24379297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
    Freedman BI; Julian BA; Pastan SO; Israni AK; Schladt D; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Hicks PJ; Palmer ND; Adams PL; Palanisamy A; Reeves-Daniel AM; Divers J
    Am J Transplant; 2015 Jun; 15(6):1615-22. PubMed ID: 25809272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Real World Impact of APOL1 Variants on Kidney Transplantation.
    Chandraker A
    Transplantation; 2016 Jan; 100(1):16-7. PubMed ID: 26566059
    [No Abstract]   [Full Text] [Related]  

  • 9. The AJT Report: news and issues that affect organ and tissue transplantation. Genetic factor may limitkidney donation.
    Pondrom S
    Am J Transplant; 2012 Nov; 12(11):2865-6. PubMed ID: 23107266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.
    Lee BT; Kumar V; Williams TA; Abdi R; Bernhardy A; Dyer C; Conte S; Genovese G; Ross MD; Friedman DJ; Gaston R; Milford E; Pollak MR; Chandraker A
    Am J Transplant; 2012 Jul; 12(7):1924-8. PubMed ID: 22487534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
    Larsen CP; Beggs ML; Saeed M; Ambruzs JM; Cossey LN; Messias NC; Walker PD; Freedman BI
    Mod Pathol; 2015 Jan; 28(1):95-102. PubMed ID: 25081748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
    Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic effect of APOL1 risk alleles in PLA2R-associated membranous glomerulopathy.
    Larsen CP; Beggs ML; Walker PD; Saeed M; Ambruzs JM; Messias NC
    Am J Kidney Dis; 2014 Jul; 64(1):161-3. PubMed ID: 24731740
    [No Abstract]   [Full Text] [Related]  

  • 15. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health disparities in kidney disease--emerging data from the human genome.
    Williams WW; Pollak MR
    N Engl J Med; 2013 Dec; 369(23):2260-1. PubMed ID: 24206461
    [No Abstract]   [Full Text] [Related]  

  • 17. The APOL1 gene and allograft survival after kidney transplantation.
    Reeves-Daniel AM; DePalma JA; Bleyer AJ; Rocco MV; Murea M; Adams PL; Langefeld CD; Bowden DW; Hicks PJ; Stratta RJ; Lin JJ; Kiger DF; Gautreaux MD; Divers J; Freedman BI
    Am J Transplant; 2011 May; 11(5):1025-30. PubMed ID: 21486385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOL1 and kidney disease: new insights leading to novel therapies.
    Freedman BI
    Am J Kidney Dis; 2015 Jul; 66(1):9-11. PubMed ID: 26111904
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial.
    Bodonyi-Kovacs G; Ma JZ; Chang J; Lipkowitz MS; Kopp JB; Winkler CA; Le TH
    J Am Soc Nephrol; 2016 Oct; 27(10):3140-3152. PubMed ID: 26940095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
    GutiƩrrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
    Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.